US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Pre-market: 226.023.02+1.35%08:28 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:585.26M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.53

T/O Rate:30.67%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

Surrozen announces FDA clearance of IND application for SZN-8141

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Piper Sandler Remains a Buy on Shattuck Labs (STTK)

Piper Sandler Remains a Buy on Regeneron (REGN)

EPF Raises Stake in IHH Healthcare to 13.245%

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Honliv Healthcare advances probe, control review in push to resume HK trading

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

Oneview Healthcare Issues New Tranche of Restricted Share Units

Cullinan Starts FDA Submission for Zipalertinib-Chemotherapy Combo in Non-Small Cell Lung Cancer

MT Newswires Live

Ramsay Health Care Reports Lapse of Performance Rights, Reducing Potential Equity Issuance

What Did The Market Misjudge About Alignment Healthcare?

Simply Wall St.

American Healthcare REIT, Inc. (AHR) Receives a Buy from BMO Capital

Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR

Fisher & Paykel Healthcare Adds Shares Under Employee Incentive Plan

Healthcare Stocks Among Top Losers

Press Release: National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘前","latestPrice":226.02,"preClose":223,"latestTime":"08:28 EDT","volume":2030,"amount":457219.742,"timestamp":1791548918307,"change":3.02,"changeRate":0.013543,"amplitude":0.01487},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Pre-Mkt","change":-4.75,"latestTime":"10-09 08:30:50 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":226.4,"askSize":400,"bidPrice":223.58,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.0041,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":226.02,"preClose":223,"latestTime":"08:28 EDT","volume":2030,"amount":457219.742,"timestamp":1791548918307,"change":3.02,"changeRate":0.013543,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526100709509335,"impliedVol":1.0277,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526100709509335,"shares":2624500,"dividePrice":0.9143,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"committee":-0.333333,"eps":0,"divideRate":0.0041,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672714416","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714416?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944215,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX), Regeneron (REGN) and Tar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LU0128526141.USD","LU1917777945.USD","LU2468319806.SGD","LABU","BBH","HCSG","BK4585","LU2362541273.HKD","LU0882574055.USD","LU0823434740.USD","BK4139","LU0889565916.HKD","LU2362541513.USD","REGN","BK4007","LU2237438978.USD","LU0823416689.USD","TBXU","LU2065731478.USD","IBB","BK4137","LU2106854487.HKD","LU0114720955.EUR","IBBQ","BK4581","LU2023250504.SGD","XBI","LU0320765992.SGD","BK4588","LU0053666078.USD","LU2362540622.SGD","BK4082","LU0289739699.SGD","LU2089984988.USD","LU2324357040.USD","TARS","LU0823434583.USD","XLV","LU0029874061.USD","LU0058720904.USD","LU1974910355.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714867","title":"Surrozen announces FDA clearance of IND application for SZN-8141","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714867","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714867?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:10","pubTimestamp":1790943056,"startTime":"0","endTime":"0","summary":"Surrozen (SRZN) announced its Investigational New Drug, IND, application for SZN-8141 has become effective, enabling the Company to advance the pro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/surrozen-announces-fda-clearance-of-ind-application-for-szn-8141-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/surrozen-announces-fda-clearance-of-ind-application-for-szn-8141-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","LABU","IND","SRZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672112037","title":"Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2672112037","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672112037?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"First patient expected to be dosed in the DUET study in the fourth quarter of 2026 Milestone triggers second closing of March 2025 private placement expected to provide approximately $95.1M in gross p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373778/0/en/surrozen-announces-fda-clearance-of-ind-application-for-szn-8141-for-the-treatment-of-diabetic-macular-edema.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMDD","LU1861559042.SGD","GAMR","AMDL","AMYY","LU2458330169.SGD","BK4575","SMHX","TEK","AMDC","ARTY","PSI","AIQ","BAI","CHPS","CNAV","DAMD","AMDG","LU1861220033.SGD","SAMD0main","TRFK","LABU","AMD","AIS","SOXX","XNTK","SMH","WISE","CHAT","IETC","SOXY","FTXL","ILDR","TTEQ","IE00BMPRXQ63.HKD","AMDY","BK4529","FAI","AMDW","USXF","LEGR","WUGI","IND","AMUU","QQQA","LU2461242641.AUD","OCT","AMDU","BK4532","AMDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672711857","title":"Piper Sandler Remains a Buy on Shattuck Labs (STTK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672711857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672711857?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940940,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Shattuck Labs today and set a price target of $15.00. Rahimi covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-shattuck-labs-sttk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-shattuck-labs-sttk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4139","BK4581","BK4588","XBI","STTK","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071900","title":"Piper Sandler Remains a Buy on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940929,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Regeneron today and set a price target of $854.00. Amin covers the Healthcare sector, f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","LU2468319806.SGD","LABU","BBH","BK4585","LU2362541273.HKD","LU0882574055.USD","LU0823434740.USD","BK4139","LU0889565916.HKD","LU2362541513.USD","REGN","LU2237438978.USD","LU0823416689.USD","TBXU","IBB","LU2106854487.HKD","LU0114720955.EUR","IBBQ","BK4581","LU2023250504.SGD","XBI","LU0320765992.SGD","BK4588","LU0053666078.USD","LU2362540622.SGD","LU0289739699.SGD","LU2089984988.USD","LU2324357040.USD","LU0823434583.USD","XLV","LU0058720904.USD","LU1974910355.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672351719","title":"EPF Raises Stake in IHH Healthcare to 13.245%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672351719","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672351719?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:59","pubTimestamp":1790938758,"startTime":"0","endTime":"0","summary":"The latest update is out from IHH Healthcare Bhd ( ($IHHHF) ). Malaysia’s Employees Provident Fund Board (EPF), a substantial shareholder in IHH He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-245?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-raises-stake-in-ihh-healthcare-to-13-245?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","HCSG","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672162716","title":"Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672162716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672162716?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:30","pubTimestamp":1790937019,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Shattuck Labs (STTK) and Atricure (ATRC). Shattuck...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-shattuck-labs-sttk-and-atricure-atrc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-shattuck-labs-sttk-and-atricure-atrc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4588","BK4139","ATRC","XLV","BK4082","LABU","STTK","LU0029874061.USD","BK4581","HCSG","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715102","title":"Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715102?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:51","pubTimestamp":1790934666,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Wave Life Sciences (WVE), Liquidia Technologies (L...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-wave-life-sciences-wve-liquidia-technologies-lqda-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-wave-life-sciences-wve-liquidia-technologies-lqda-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PJP","LU0208291251.USD","IE0009355771.USD","LU1721429741.USD","LU0882574055.USD","LU0114720955.EUR","LU2089984988.USD","WVE","XBI","LU1670628061.USD","LU1670627923.USD","LU0128526141.USD","LU1983299246.USD","LU0868494617.USD","LU1914381329.SGD","ABT","LU1691799644.USD","SG9999004303.SGD","LU0266013472.USD","BK4581","IE0002141913.USD","LQDA","LU2211815571.USD","LABU","BK4568","LU2237957902.USD","LU0070302665.USD","IHI","XLV","LU2237957811.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","BK4566","LU0432979614.USD","LU2324357040.USD","LU1989763427.SGD","BK4504","LU1023059063.AUD","SGXZ41872573.SGD","LU0122379950.USD","LU0029874061.USD","BK4592","SG9999002224.SGD","LU1061106388.HKD","IE00B4R5TH58.HKD","HCSG","LU0289739699.SGD","TMED","BK4007","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716727","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716727","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716727?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:51","pubTimestamp":1790934660,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373672/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4137","LABU","BK4585","XLV","LU0128526141.USD","BK4581","HCSG","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715480","title":"Honliv Healthcare advances probe, control review in push to resume HK trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715480?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:42","pubTimestamp":1790934174,"startTime":"0","endTime":"0","summary":"An update from Honliv Healthcare Management Group Co Ltd ( ($HK:9906) ) is now available. Honliv Healthcare said it continues to work with advisers...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/honliv-healthcare-advances-probe-control-review-in-push-to-resume-hk-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/honliv-healthcare-advances-probe-control-review-in-push-to-resume-hk-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","BK4588","BK4581","BK4585","LU0128526141.USD","HCSG","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713007","title":"Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713007?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:20","pubTimestamp":1790932825,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Idexx Laboratories (IDXX) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362540622.SGD","HCSG","IBB","LU2106854487.HKD","GB00B4LPDJ14.GBP","BK4082","LU0170899867.USD","LU0882574055.USD","LU0823434583.USD","LABU","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU0823434740.USD","LU2237438978.USD","XLV","LU1989771016.USD","XBI","LU2468319806.SGD","LU0053666078.USD","BK4567","LU2089984988.USD","LU0345774391.USD","LU1941712348.USD","BK4137","LU1917777945.USD","PAWZ","GB00B4QBRK32.GBP","LU0345774631.USD","LU0690374615.EUR","BK4139","LU0320765992.SGD","LU2324357040.USD","LU1941712264.USD","LU0029874061.USD","LU1974910355.USD","LU2362541273.HKD","IDXX","LU0889565916.HKD","BK4504","BBH","BK4588","LU2404859667.USD","BK4581","REGN","LU0128526141.USD","TBXU","IBBQ","LU2023250504.SGD","LU2404859741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672771881","title":"Oneview Healthcare Issues New Tranche of Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2672771881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672771881?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:17","pubTimestamp":1790929072,"startTime":"0","endTime":"0","summary":"Oneview Healthcare Chess Depository Interests repr 1 ( ($AU:ONE) ) has provided an update. Oneview Healthcare PLC has notified the market of the is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-issues-new-tranche-of-restricted-share-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-issues-new-tranche-of-restricted-share-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","HCSG","XLV","BK4137","LU0029874061.USD","LU0128526141.USD","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790775","title":"Cullinan Starts FDA Submission for Zipalertinib-Chemotherapy Combo in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790775","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790775?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:10","pubTimestamp":1790928630,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics  has started submitting its new drug application to the US Food and Drug Administration for zipalertinib plus platinum-based chemotherapy in previously untreated non-small cell lung cancer,  the company said late Thursday.The filing is being reviewed under the FDA's Real-Time Oncology Review program, which allows regulators to assess clinical data ahead of a full application.The submission is supported by results from a phase 3 trial showing a significant progression-free survival benefit over chemotherapy alone, the company said.Cullinan expects to complete the regulatory submission by year-end 2026.The company is eligible for milestone payments of $30 million and $100 million tied to potential second-line and first-line approvals, respectively, it said.Cullinan said Zipalertinib remains an investigational drug and has not been approved by any health authority.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4139","LABU","CGEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672964227","title":"Ramsay Health Care Reports Lapse of Performance Rights, Reducing Potential Equity Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672964227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672964227?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:37","pubTimestamp":1790908670,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has provided an update. Ramsay Health Care has notified the market of the cessation of a tranche of performance ri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-reports-lapse-of-performance-rights-reducing-potential-equity-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-reports-lapse-of-performance-rights-reducing-potential-equity-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","LABU","BK4585","BK4215","REZ","BK4581","XBI","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796012","title":"What Did The Market Misjudge About Alignment Healthcare?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796012","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796012?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:24","pubTimestamp":1790907870,"startTime":"0","endTime":"0","summary":"If you backed Alignment Healthcare for its rapid member growth, sub-10% SG&A, and bullish analyst narratives around digital care for seniors, the outcome was harsh. For Alignment Healthcare shareholders, the loss from the start of the year was 61.7%, including dividends. If you had bought on 1 January assuming 34.9% revenue growth, a 3.1% margin, and a 24.2x P/E by 2028, what did that thesis miss about regulatory risk, competition, and now, whistleblower accounting claims?\nNarratives are how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4154","ALHC","BK4588","BK4585","LABU","BK4539","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672933407","title":"American Healthcare REIT, Inc. (AHR) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2672933407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672933407?lang=en_us&edition=fundamental","pubTime":"2026-10-02 08:36","pubTimestamp":1790901378,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on American Healthcare REIT, Inc. today and set a price target of $65.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","MDIV","BK4585","LABU","BPRE","BK4588","REIT","AHR","YLDW","XBI","XLV","IQRA","IVRA","RJMG","RNTY","DFRA","BK4225","PSCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672798115","title":"Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR","url":"https://stock-news.laohu8.com/highlight/detail?id=2672798115","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672798115?lang=en_us&edition=fundamental","pubTime":"2026-10-02 07:52","pubTimestamp":1790898737,"startTime":"0","endTime":"0","summary":"The latest update is out from Otsuka Holdings Co ( ($JP:4578) ). Taiho Pharmaceutical, an Otsuka Holdings subsidiary, has begun submitting a New Dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/otsuka-unit-taiho-advances-zipalertinib-nda-for-egfr-exon-20-nsclc-under-fda-rtor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/otsuka-unit-taiho-advances-zipalertinib-nda-for-egfr-exon-20-nsclc-under-fda-rtor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767746","title":"Fisher & Paykel Healthcare Adds Shares Under Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767746?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:58","pubTimestamp":1790891903,"startTime":"0","endTime":"0","summary":"An announcement from Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) is now available. Fisher & Paykel Healthcare Corporation Limited ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-adds-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-adds-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","FPH.NZ","BK4581","XBI","BK8004","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762292","title":"Healthcare Stocks Among Top Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762292?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:55","pubTimestamp":1790888100,"startTime":"0","endTime":"0","summary":"Shares in the healthcare industry fell the most on a modestly positive day for the broader U.S. equities complex.France's Sanofi and Regeneron Pharmaceuticals said they would expand their longstanding alliance to jointly develop and market new immunology medicines, in a deal that could net the U.S. drugmaker up to $8 billion.  The two companies have collaborated for more than two decades. Under the new agreement, Tarrytown, N.Y.-based Regeneron will receive $1 billion upfront from Sanofi and be eligible for additional payments of up to $7 billion subject to development, regulatory and commercial targets, the companies said.Foghorn Therapeutics said it would be slashing nearly half of its workforce after scrapping a drug development partnership with Eli Lilly, forcing the biotech into defensive mode as it attempts to conserve cash.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","BK4137","LABU","LU0128526141.USD","LU0029874061.USD","XBI","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672176280","title":"Press Release: National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2672176280","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672176280?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:30","pubTimestamp":1790886600,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP) (the \"Company\") announced today that its Board of Directors declared a quarterly dividend of $0.075 per s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFA.SI","BK4225","BK4588","BK4581","CLR.SI","BK4585","SRT.SI","JJJ.SI","XLV","XBI","GLS.SI","REET","NHP","LABU","SRU.SI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":12,"totalSize":427,"code":"91000000","status":"200"}]}}